|
Originally published In Press as doi:10.1074/jbc.M111047200 on November 28, 2001
J. Biol. Chem., Vol. 277, Issue 6, 4422-4427, February 8, 2002
Agonist-induced Force Enhancement
THE ROLE OF ISOFORMS AND PHOSPHORYLATION OF THE MYOSIN-TARGETING
SUBUNIT OF MYOSIN LIGHT CHAIN PHOSPHATASE*
Christopher T.
Richards ,
Ozgur
Ogut , and
Frank V.
Brozovich §¶
From the Departments of § Medicine and
Physiology and Biophysics, Case Western Reserve
University, Cleveland, Ohio 44106
The magnitude of agonist-induced
Ca2+ sensitization of force is
tissue-dependent, but an explanation for this diversity is
unknown. Ca2+ sensitization is thought to involve a
G-protein-mediated inhibition of myosin light chain phosphatase
activity by phosphorylation of the myosin-targeting subunit (MYPT). The
MYPT has two isoforms that differ by a central insert, which lies near
this phosphorylation site. Expression of MYPT isoforms is both
developmentally regulated and tissue-specific. We hypothesized that the
presence or absence of the central insert determines the magnitude of
agonist-induced Ca2+ sensitization. Throughout development,
the chicken aorta exclusively expresses the splice-in MYPT isoform, and
guanosine 5'-O-(thiotriphosphate) (GTP S) produces a
significant force enhancement. Early during development, the chicken
gizzard expresses the splice-in MYPT isoform, and GTP S produced a
Ca2+ sensitization. In the gizzard coincident with the
shift in expression from the splice-in to splice-out MYPT isoform,
GTP S no longer produced force enhancement. In addition, adenosine
5'-O-(thiotriphosphate) (ATP S) phosphorylated only adult
gizzard tissue, the only tissue that did not demonstrate a
Ca2+ sensitization. These results suggest that the relative
expression of splice-in/splice-out MYPT isoforms determines the
magnitude of agonist-induced force enhancement and that MYPT
phosphorylation is not required for Ca2+ sensitization.
*
This work was supported by National Institutes of Health
Grant HL64137.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of
Physiology and Biophysics, 10900 Euclid Ave., Cleveland, OH 44106-4970. Tel.: 216-844-8955; Fax: 216-368-5586; E-mail: fxb9@po.cwru.edu.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. M. Karim, A. Y. Rhee, A. M. Given, M. D. Faulx, B. D. Hoit, and F. V. Brozovich
Vascular Reactivity in Heart Failure: Role of Myosin Light Chain Phosphatase
Circ. Res.,
September 17, 2004;
95(6):
612 - 618.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Q. Huang, S. A. Fisher, and F. V. Brozovich
Unzipping the Role of Myosin Light Chain Phosphatase in Smooth Muscle Cell Relaxation
J. Biol. Chem.,
January 2, 2004;
279(1):
597 - 603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. SOMLYO and A. V. SOMLYO
Ca2+ Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase
Physiol Rev,
October 1, 2003;
83(4):
1325 - 1358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. V. Brozovich
Rho Signaling: Agonist Stimulation and Depolarization Come Together
Circ. Res.,
September 19, 2003;
93(6):
481 - 483.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. P. Dirksen, S. A. Mohamed, and S. A. Fisher
Splicing of a Myosin Phosphatase Targeting Subunit 1 Alternative Exon Is Regulated by Intronic Cis-elements and a Novel Bipartite Exonic Enhancer/Silencer Element
J. Biol. Chem.,
March 7, 2003;
278(11):
9722 - 9732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. SOMLYO, C. PHELPS, C. DIPIERRO, M. ETO, P. READ, M. BARRETT, J. J. GIBSON, M. C. BURNITZ, C. MYERS, and A. P. SOMLYO
Rho kinase and matrix metalloproteinase inhibitors cooperate to inhibit angiogenesis and growth of human prostate cancer xenotransplants
FASEB J,
February 1, 2003;
17(2):
223 - 234.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Borman, J. A. MacDonald, A. Muranyi, D. J. Hartshorne, and T. A. J. Haystead
Smooth Muscle Myosin Phosphatase-associated Kinase Induces Ca2+ Sensitization via Myosin Phosphatase Inhibition
J. Biol. Chem.,
June 21, 2002;
277(26):
23441 - 23446.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. V. Brozovich
Myosin Light Chain Phosphatase: It Gets Around
Circ. Res.,
March 22, 2002;
90(5):
500 - 502.
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|